Literature DB >> 20130897

Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil.

Shiv Saidha, S Murphy, A Ronayne, P McCarthy, M J Hennessy, T Counihan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20130897     DOI： 10.1007/s00415-010-5476-9

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.

Authors:  Michael P Malter; Christoph Helmstaedter; Horst Urbach; Angela Vincent; Christian G Bien
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

2.  Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.

Authors:  Beau M Ances; Roberta Vitaliani; Robert A Taylor; David S Liebeskind; Alfredo Voloschin; David J Houghton; Steven L Galetta; Marc Dichter; Abass Alavi; Myrna R Rosenfeld; Josep Dalmau
Journal:  Brain       Date:  2005-05-11       Impact factor: 13.501

3.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

4.  Plasma exchange for anti GAD associated non paraneoplastic limbic encephalitis.

Authors:  Gustavo Mazzi; Dina De Roia; Barbara Cruciatti; Sabrina Matà; Raffaele Catapano
Journal:  Transfus Apher Sci       Date:  2008-10-26       Impact factor: 1.764

5.  Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?

Authors:  F Blanc; E Ruppert; C Kleitz; M P Valenti; B Cretin; R L Humbel; J Honnorat; I J Namer; E Hirsch; L Manning; J de Seze
Journal:  J Neurol Sci       Date:  2009-09-27       Impact factor: 3.181

6.  Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.

Authors:  Angela Vincent; Camilla Buckley; Jonathan M Schott; Ian Baker; Bonnie-Kate Dewar; Niels Detert; Linda Clover; Abigail Parkinson; Christian G Bien; Salah Omer; Bethan Lang; Martin N Rossor; Jackie Palace
Journal:  Brain       Date:  2004-02-11       Impact factor: 13.501

7.  Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.

Authors:  Goran Rakocevic; Raghavanpillai Raju; Marinos C Dalakas
Journal:  Arch Neurol       Date:  2004-06

8.  Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency.

Authors:  Cigdem I Akman; Marc C Patterson; Arye Rubinstein; Ronit Herzog
Journal:  Dev Med Child Neurol       Date:  2009-02-03       Impact factor: 5.449

Review 9.  Limbic encephalitis and variants: classification, diagnosis and treatment.

Authors:  Erdem Tüzün; Josep Dalmau
Journal:  Neurologist       Date:  2007-09       Impact factor: 1.398

10.  Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

Authors:  J Kim; M Namchuk; T Bugawan; Q Fu; M Jaffe; Y Shi; H J Aanstoot; C W Turck; H Erlich; V Lennon; S Baekkeskov
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307
View more
  9 in total

1.  Current approaches to the treatment of paraneoplastic encephalitis.

Authors:  Wolfgang Grisold; Bruno Giometto; Roberta Vitaliani; Stefan Oberndorfer
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

2.  Atypical presentation of an elderly male with autoimmune encephalitis: anti-LG1 limbic encephalitis.

Authors:  Binita Bhandari; Bikash Basyal; Selin Sendil; Resha Khanal; Sunita Neupane; Vinod Nookala
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-08-02

3.  Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report.

Authors:  Masahito Takagi; Hiroshi Yamasaki; Keiko Endo; Tetsuya Yamada; Keizo Kaneko; Yoshitomo Oka; Etsuro Mori
Journal:  BMC Neurol       Date:  2011-12-21       Impact factor: 2.474

4.  Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study.

Authors:  Masahito Takagi; Yasushi Ishigaki; Kenji Uno; Shojiro Sawada; Junta Imai; Keizo Kaneko; Yutaka Hasegawa; Tetsuya Yamada; Ai Tokita; Kazumi Iseki; Shigenori Kanno; Yoshiyuki Nishio; Hideki Katagiri; Etsuro Mori
Journal:  BMC Neurol       Date:  2013-07-09       Impact factor: 2.474

Review 5.  Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies.

Authors:  Matteo Gastaldi; Anaïs Thouin; Angela Vincent
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

6.  A unique combination of autoimmune limbic encephalitis, type 1 diabetes, and Stiff person syndrome associated with GAD-65 antibody.

Authors:  Chandra Mohan Sharma; Rajendra Kumar Pandey; Banshi Lal Kumawat; Dinesh Khandelwal; Pankaj Gandhi
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

7.  GAD65 Positive Autoimmune Limbic Encephalitis: A Case Report and Review of Literature.

Authors:  Abhishek Sharma; Divyanshu Dubey; Anshudha Sawhney; Kalyana Janga
Journal:  J Clin Med Res       Date:  2012-11-11

8.  Assessment of the effects of glutamic acid decarboxylase antibodies and trace elements on cognitive performance in older adults.

Authors:  Ahmad H Alghadir; Sami A Gabr; Einas S Al-Eisa
Journal:  Clin Interv Aging       Date:  2015-12-03       Impact factor: 4.458

9.  Treatment of paraneoplastic cerebellar degeneration.

Authors:  John E Greenlee
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.